The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMBIT BIOSCIENCES CORP | COM | 02318X100 | 0 | 24 | SH | SOLE | 24 | 0 | 0 | ||
| AMBIT BIOSCIENCES CORP | COM | 02318X100 | 0 | 22 | SH | OTR | 1 | 0 | 22 | 0 | |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 12,825 | 182,300 | SH | SOLE | 182,300 | 0 | 0 | ||
| DENDREON CORP | COM | 24823Q107 | 238 | 79,600 | SH | OTR | 1 | 0 | 79,600 | 0 | |
| ENDOCYTE INC | COM | 29269A102 | 4,974 | 465,763 | SH | SOLE | 465,763 | 0 | 0 | ||
| INTERMUNE INC | NOTE 2.50% 9/15/18 | 45884XAE3 | 10,575 | 12,000,000 | PRN | SOLE | 12,000,000 | 0 | 0 | ||
| MANNKIND CORP | COM | 56400P201 | 5,566 | 1,070,419 | SH | SOLE | 1,070,419 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 15,608 | 938,543 | SH | SOLE | 938,543 | 0 | 0 | ||
| ONCOGENEX PHARMACEUTICALS INC | COM | 68230A106 | 8,616 | 1,033,100 | SH | SOLE | 1,033,100 | 0 | 0 | ||
| OPKO HEALTH INC | NOTE 3.0% 2/1/33 | 68375NAA1 | 17,050 | 14,000,000 | PRN | SOLE | 14,000,000 | 0 | 0 | ||
| OPKO HEALTH INC | COM | 68375N103 | 94 | 11,195 | SH | SOLE | 11,195 | 0 | 0 | ||
| PDL BIOPHARMA INC | NOTE 2.875% 2/15/15 | 69329YAE4 | 38,616 | 25,974,000 | PRN | SOLE | 25,974,000 | 0 | 0 | ||
| SALIX PHARMACEUTICALS INC | COM | 795435106 | 26,982 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| SOPHIRIS BIO INC | COM | 83578Q209 | 1,850 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||